Robert D. King - 28 Feb 2023 Form 4 Insider Report for Corteva, Inc. (CTVA)

Reporting relationship: EVP, Crop Protection Business
Issuer ticker: CTVA
Reported as of: 28 Feb 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Mar 2023, 15:51:23 UTC
Prior SEC filing: 06 Apr 2022
Next SEC filing: 06 Apr 2023
Source filing: View source filing
Reporting owner signature: /s/Abigail Jarrell, by power-of-attorney

Key filing fact

Robert D. King filed Form 4 for Corteva, Inc. (CTVA) on 02 Mar 2023.

Key facts

This page summarizes Robert D. King's Form 4 filing for Corteva, Inc. (CTVA).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 02 Mar 2023, 15:51.

Change

Previous filing in this sequence was filed on 06 Apr 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CTVA transaction

Common Stock

Award

Transaction value: $0
Shares: +4,817
Change %: +7.7%
Price: $0.000000
Shares after: 67,665
Date: 28 Feb 2023
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CTVA transaction Derivative

Non-Qualified Stock Option (right-to-buy)

Award

Transaction value: $0
Shares: +14,006
Change %
Price: $0.000000
Shares after: 14,006
Date: 28 Feb 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 14,006
Exercise price: $62.29
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents grant of restricted stock units which vests in three equal annual installments beginning on February 28, 2024.

Footnote F2

Includes acquisition of shares pursuant to dividend reinvestment.

Footnote F3

The option vests in three equal annual installments beginning on February 28, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .